Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting learning session on bridging the gap between AMR surveillance and antibiotic policy for appropriate therapy.
In this webinar, a panel discussion would take place involving Dr Subramanian Swaminathan as the primary speaker and involving other panelists to participate and discuss the important facts associated with antibiotic resistance and the policies to be adapted for introducing an appropriate therapy.
Antimicrobial surveillance is an essential pillar in fighting against antimicrobial resistance (AMR). There is a lack of understanding and practical guidance on how surveillance data should be linked to AMS activities. Moreover, it becomes much more complex in the hospital setting because of the structural heterogeneity of hospital facilities and services.
Therefore, the webinar will give you an overall guidance on bridging the gap between AMR surveillance and antibiotic policy for appropriate therapy. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions
See More Webinars @ Hidoc Webinars
1.
Similar survival seen with simple versus radical hysterectomy for cervical cancer
2.
Clinical trial could lead to new 'gold standard' test for prostate cancer detection
3.
The FDA approves alexinib as an adjuvant treatment for non-small cell lung cancer.
4.
Effective Intralesional Melanoma Therapy May Involve Systemic Effects.
5.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
1.
Understanding Villous Adenoma: Causes, Symptoms, and Treatments
2.
An Introduction To The CA 15-3 Tumor Marker Test For Cancer Patients
3.
Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification
4.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
5.
Understanding Neutrophilia: Causes, Symptoms, and Treatment Options
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Navigating the Complexities of Ph Negative ALL - Part XVI
2.
Updates on the First Line Management of ALK+ NSCLC
3.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
5.
Efficient Management of First line ALK-rearranged NSCLC - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation